977 related articles for article (PubMed ID: 35178126)
1. Interplay between Dysbiosis of Gut Microbiome, Lipid Metabolism, and Tumorigenesis: Can Gut Dysbiosis Stand as a Prognostic Marker in Cancer?
Chattopadhyay I; Gundamaraju R; Jha NK; Gupta PK; Dey A; Mandal CC; Ford BM
Dis Markers; 2022; 2022():2941248. PubMed ID: 35178126
[TBL] [Abstract][Full Text] [Related]
2. Differential modulation by Akkermansia muciniphila and Faecalibacterium prausnitzii of host peripheral lipid metabolism and histone acetylation in mouse gut organoids.
Lukovac S; Belzer C; Pellis L; Keijser BJ; de Vos WM; Montijn RC; Roeselers G
mBio; 2014 Aug; 5(4):. PubMed ID: 25118238
[TBL] [Abstract][Full Text] [Related]
3. Interactions between gut microbiota and non-alcoholic liver disease: The role of microbiota-derived metabolites.
Ding Y; Yanagi K; Cheng C; Alaniz RC; Lee K; Jayaraman A
Pharmacol Res; 2019 Mar; 141():521-529. PubMed ID: 30660825
[TBL] [Abstract][Full Text] [Related]
4. Diet as a modifiable factor in tumorigenesis: Focus on microbiome-derived bile acid metabolites and short-chain fatty acids.
Ahmad F; Saha P; Singh V; Wahid M; Mandal RK; Nath Mishra B; Fagoonee S; Haque S
Food Chem; 2023 Jun; 410():135320. PubMed ID: 36610090
[TBL] [Abstract][Full Text] [Related]
5. Interplay between bile acids and the gut microbiota promotes intestinal carcinogenesis.
Wang S; Dong W; Liu L; Xu M; Wang Y; Liu T; Zhang Y; Wang B; Cao H
Mol Carcinog; 2019 Jul; 58(7):1155-1167. PubMed ID: 30828892
[TBL] [Abstract][Full Text] [Related]
6. METABOLIC DYSBIOSIS OF THE GUT MICROBIOTA AND ITS BIOMARKERS.
Sitkin SI; Tkachenko EI; Vakhitov TY
Eksp Klin Gastroenterol; 2016 Jul; 12(12):6-29. PubMed ID: 29889418
[TBL] [Abstract][Full Text] [Related]
7. Bile acid dysregulation, gut dysbiosis, and gastrointestinal cancer.
Tsuei J; Chau T; Mills D; Wan YJ
Exp Biol Med (Maywood); 2014 Nov; 239(11):1489-504. PubMed ID: 24951470
[TBL] [Abstract][Full Text] [Related]
8. Connecting the immune system, systemic chronic inflammation and the gut microbiome: The role of sex.
Rizzetto L; Fava F; Tuohy KM; Selmi C
J Autoimmun; 2018 Aug; 92():12-34. PubMed ID: 29861127
[TBL] [Abstract][Full Text] [Related]
9. The impact of metabolites derived from the gut microbiota on immune regulation and diseases.
Ohno H
Int Immunol; 2020 Sep; 32(10):629-636. PubMed ID: 32564086
[TBL] [Abstract][Full Text] [Related]
10. Protective effect of agaro-oligosaccharides on gut dysbiosis and colon tumorigenesis in high-fat diet-fed mice.
Higashimura Y; Naito Y; Takagi T; Uchiyama K; Mizushima K; Ushiroda C; Ohnogi H; Kudo Y; Yasui M; Inui S; Hisada T; Honda A; Matsuzaki Y; Yoshikawa T
Am J Physiol Gastrointest Liver Physiol; 2016 Mar; 310(6):G367-75. PubMed ID: 26767984
[TBL] [Abstract][Full Text] [Related]
11. Fecal metabonomics combined with 16S rRNA gene sequencing to analyze the changes of gut microbiota in rats with kidney-yang deficiency syndrome and the intervention effect of You-gui pill.
Chen R; Wang J; Zhan R; Zhang L; Wang X
J Ethnopharmacol; 2019 Nov; 244():112139. PubMed ID: 31401318
[TBL] [Abstract][Full Text] [Related]
12. Dysbiotic Gut Microbiota-Derived Metabolites and Their Role in Non-Communicable Diseases.
Tan J; Taitz J; Nanan R; Grau G; Macia L
Int J Mol Sci; 2023 Oct; 24(20):. PubMed ID: 37894934
[TBL] [Abstract][Full Text] [Related]
13. Short-chain fatty acids: microbial metabolites that alleviate stress-induced brain-gut axis alterations.
van de Wouw M; Boehme M; Lyte JM; Wiley N; Strain C; O'Sullivan O; Clarke G; Stanton C; Dinan TG; Cryan JF
J Physiol; 2018 Oct; 596(20):4923-4944. PubMed ID: 30066368
[TBL] [Abstract][Full Text] [Related]
14. Effects of ad libitum Free-Choice Access to Freshly Squeezed Domestic White Asparagus Juice on Intestinal Microbiota Composition and Universal Bio-Markers of Immuno-Metabolic Homeostasis and General Health in Middle-Aged Female and Male C57BL/6 Mice.
Ghadimi D; Frahm SO; Röcken C; Ebsen M; Schwiertz A; Fölster-Holst R; Bockelmann W; Heller KJ
Endocr Metab Immune Disord Drug Targets; 2022; 22(4):401-414. PubMed ID: 34463231
[TBL] [Abstract][Full Text] [Related]
15. Exploring the Role of Gut Microbiome in Colon Cancer.
Chattopadhyay I; Dhar R; Pethusamy K; Seethy A; Srivastava T; Sah R; Sharma J; Karmakar S
Appl Biochem Biotechnol; 2021 Jun; 193(6):1780-1799. PubMed ID: 33492552
[TBL] [Abstract][Full Text] [Related]
16. Gut-liver axis-mediated mechanism of liver cancer: A special focus on the role of gut microbiota.
Ohtani N; Hara E
Cancer Sci; 2021 Nov; 112(11):4433-4443. PubMed ID: 34533882
[TBL] [Abstract][Full Text] [Related]
17. Role of microbiota-derived short-chain fatty acids in cancer development and prevention.
Mirzaei R; Afaghi A; Babakhani S; Sohrabi MR; Hosseini-Fard SR; Babolhavaeji K; Khani Ali Akbari S; Yousefimashouf R; Karampoor S
Biomed Pharmacother; 2021 Jul; 139():111619. PubMed ID: 33906079
[TBL] [Abstract][Full Text] [Related]
18. Dietary lipids, gut microbiota and lipid metabolism.
Schoeler M; Caesar R
Rev Endocr Metab Disord; 2019 Dec; 20(4):461-472. PubMed ID: 31707624
[TBL] [Abstract][Full Text] [Related]
19. Gut microbiota and host metabolism in liver cirrhosis.
Usami M; Miyoshi M; Yamashita H
World J Gastroenterol; 2015 Nov; 21(41):11597-608. PubMed ID: 26556989
[TBL] [Abstract][Full Text] [Related]
20. Perturbation of the lipid metabolism and intestinal inflammation in growing pigs with low birth weight is associated with the alterations of gut microbiota.
Huang SM; Wu ZH; Li TT; Liu C; Han DD; Tao SY; Pi Y; Li N; Wang JJ
Sci Total Environ; 2020 Jun; 719():137382. PubMed ID: 32114228
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
